$8.88
0.323.80%
Last update: Jun 9, 10:18 AM
Kura Oncology Inc Earnings Estimates
KURANASDAQ
Kura Oncology Earnings Estimates, EPS & Revenue | NASDAQ:KURA
Kura Oncology (KURA) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.91 and quarterly revenue of $19.04M.
In the most recent quarter (Q1), Kura Oncology reported EPS of $-0.83, missing estimates of $-0.80 by 0.04%. Revenue came in at $18.27M, missing the estimate of $23.75M by 0.23%.
Kura Oncology has missed EPS estimates in 5 consecutive quarters.
Over the last 4 quarters, Kura Oncology has averaged an EPS surprise of 1.17% and a revenue surprise of 0.55%.
Earnings Date
Aug 6
EPS Estimate
$-0.910
Quarterly Revenue Estimate
$19.04M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$71.64M
Kura Oncology Earnings History
Analyze the earnings history of Kura Oncology using advanced sorting and filters.
Loading calendar...
Kura Oncology (KURA) Earnings Per Share
The chart below shows Kura Oncology's reported EPS compared to analyst estimates over recent quarters.
Kura Oncology (KURA) Revenue
The chart below shows Kura Oncology's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Kura Oncology (NASDAQ:KURA) reporting earnings?
Kura Oncology (KURA) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for Kura Oncology (NASDAQ:KURA)?
The Actual EPS was $-0.83, which missed the estimate of $-0.80.
What were Kura Oncology’s (NASDAQ:KURA) revenues?
The Actual Revenue was $18.27M, which missed the estimate of $23.75M.
